CN102115718A - Recombinant strain for expressing beta-galactosidase and construction method and application thereof - Google Patents
Recombinant strain for expressing beta-galactosidase and construction method and application thereof Download PDFInfo
- Publication number
- CN102115718A CN102115718A CN201010591434.5A CN201010591434A CN102115718A CN 102115718 A CN102115718 A CN 102115718A CN 201010591434 A CN201010591434 A CN 201010591434A CN 102115718 A CN102115718 A CN 102115718A
- Authority
- CN
- China
- Prior art keywords
- beta
- galactosidase
- bacterial strain
- lactose
- galactosidase enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010005774 beta-Galactosidase Proteins 0.000 title claims abstract description 46
- 102000005936 beta-Galactosidase Human genes 0.000 title claims abstract description 11
- 238000010276 construction Methods 0.000 title claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims abstract description 33
- 108090000790 Enzymes Proteins 0.000 claims abstract description 33
- 239000013604 expression vector Substances 0.000 claims abstract description 6
- 101100377299 Arabidopsis thaliana ZHD13 gene Proteins 0.000 claims abstract description 5
- 238000009928 pasteurization Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 230000001580 bacterial effect Effects 0.000 claims description 23
- 241000235648 Pichia Species 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 12
- 241000589499 Thermus thermophilus Species 0.000 claims description 10
- 238000012216 screening Methods 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 5
- 241001052560 Thallis Species 0.000 claims description 3
- 238000012262 fermentative production Methods 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 36
- 239000008101 lactose Substances 0.000 abstract description 36
- 229940088598 enzyme Drugs 0.000 abstract description 32
- 235000013336 milk Nutrition 0.000 abstract description 20
- 239000008267 milk Substances 0.000 abstract description 20
- 210000004080 milk Anatomy 0.000 abstract description 20
- 230000001954 sterilising effect Effects 0.000 abstract description 14
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 14
- 241000051160 Thermus thermophilus HB27 Species 0.000 abstract description 7
- 102100026189 Beta-galactosidase Human genes 0.000 abstract description 5
- 108010093031 Galactosidases Proteins 0.000 abstract description 4
- 108010059881 Lactase Proteins 0.000 abstract description 3
- 235000013365 dairy product Nutrition 0.000 abstract description 3
- 229940116108 lactase Drugs 0.000 abstract description 3
- 102000002464 Galactosidases Human genes 0.000 abstract description 2
- 241000235058 Komagataella pastoris Species 0.000 abstract description 2
- 238000010367 cloning Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 229960002203 tilactase Drugs 0.000 description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 10
- 238000006460 hydrolysis reaction Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 201000010538 Lactose Intolerance Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 235000020247 cow milk Nutrition 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 229930003756 Vitamin B7 Natural products 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000011735 vitamin B7 Substances 0.000 description 4
- 235000011912 vitamin B7 Nutrition 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 150000008195 galaktosides Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- RYVMUASDIZQXAA-UHFFFAOYSA-N pyranoside Natural products O1C2(OCC(C)C(OC3C(C(O)C(O)C(CO)O3)O)C2)C(C)C(C2(CCC3C4(C)CC5O)C)C1CC2C3CC=C4CC5OC(C(C1O)O)OC(CO)C1OC(C1OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OCC(O)C(O)C1O RYVMUASDIZQXAA-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 101100055085 Agrocybe aegerita Agr4 gene Proteins 0.000 description 1
- 102100036826 Aldehyde oxidase Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101150051118 PTM1 gene Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 108010027322 single cell proteins Proteins 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012859 sterile filling Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a recombinant strain for expressing beta-galactosidase and a construction method and application thereof. The galactosidase gene bgal of Thermus thermophilus HB27 is obtained by cloning, and is inserted into a eukaryotic expression vector pPIC9K, and transformed into a Pichia pastoris strain GS 115, so that the expression quantity of beta-galactosidase can reach 14000U/ml. The molecular weight of beta-galactosidase gene bgal expression is 58Dk, the optimum temperature is 70 ℃, and the optimum temperature is stable. The lactase has the highest hydrolytic activity and better stability at pH6.5. The beta-galactosidase with high expression can be directly used for pasteurization of dairy products, can degrade lactose while sterilizing, and avoids secondary pollution caused by adding enzyme after sterilization. At 60 degrees, 30 minutes, HB27 galactosidase was able to degrade 90% of lactose in milk.
Description
Technical field
The present invention relates to a kind of recombinant bacterial strain and construction process and application of expressing beta-galactosidase enzymes, belong to biological technical field.
Background technology
Beta-galactosidase enzymes (EC 3.2.1.23) formal name used at school is β-D-galactoside galactohydrolase (hereinafter to be referred as tilactase), Sumylact L by name commonly used, and this enzyme can hydrolyze lactose into and be semi-lactosi and glucose.
Tilactase is used for the milk-product industry the earliest, because milk occupies very big proportion in westerner's dietary structure, so abroad to the research of tilactase early, many research work mainly concentrate in the diagnoses and treatment of low lactose milk processing and lactose intolerance (Lactose Intolerance).Lactose is a distinctive carbohydrate in the Mammals milk, and lactose-content is different because of kind in the Mammals milk, and lactose-content is 6.7%. in the human milk, and the Lactose in Milk average content is 4.5-5%.Although cow's milk and milk-product thereof have the good reputation of " being close to perfect food ", in China, the development of milk-product still is in the junior stage, and wherein lactose intolerance is the one of the main reasons that limits its development.Because lactose need be through being hydrolyzed into utilizations that just can be absorbed by the body behind semi-lactosi and the glucose, so the cause of disease of lactose intolerance mainly is because due to the galactoside enzyme activity hangs down on the mucous membrane of small intestine by mucous membrane of small intestine epithelial cell excretory tilactase.Lactose in Milk can not get hydrolysis, and lactose concn improves in the small intestine, and osmotic pressure is increased, thereby the moisture content that causes entering in the enteric cavity improves, and the symptom of its generation is that abdominal pressure increases, inflatable, stomachache and diarrhoea.The mucous membrane of small intestine lactase activity is higher after most Mammals births, can digest and assimilate lactose from breast milk or other milk-product, after the ablactation, lactase activity descends gradually with age growth, galactosidase activity only is the 5-10% of normal infant level to being grown up afterwards, and develops into lactose intolerance gradually.Lactose intolerance affects the absorption of the people (especially Asia and African) in the whole world about 70% to breast according to statistics.
Producing low lactose milk, is the best method that overcomes lactose intolerance at present.Classical way be with fresh milk behind pasteurization, be cooled to 40-45 ℃, add tilactase and insulation, make lactose hydrolysis.Discover when lactose hydrolysis ratio is 70-80%, can solve the lactose intolerance problem, can produce sapid product again.Commercialization already outside the producing country of low lactose milk, domestic then ground zero.The mode of production of low lactose milk has multiple, a kind of in above-mentioned just wherein many production methods.Theoretically, the low lactose milk production method has physical removal method, chemical acid-hydrolysis method, enzyme hydrolysis method and genetic engineering technique method.Wherein enzyme hydrolysis method is owing to the reaction conditions gentleness, and product is simple, does not destroy other nutritive ingredients in the cow's milk, and the side reaction product of generation is less, and mouthfeel is better, has obtained promoting widely.Up to now, enzyme hydrolysis method is to produce low the most safe, practical, the effective means of lactose cow's milk.Enzyme hydrolysis method is produced in the process of low lactose milk, enzyme be added with 2 kinds of modes.A kind of is with the optimum temps of raw dairy process pasteurize postcooling to the tilactase effect, adds enzyme and also is incubated for some time under this temperature, makes it reach desired lactose hydrolysis degree, then product is sterilized, and carries out sterile filling.This method is simple to operate, product is not easy to be polluted, but the Maillard reaction that takes place during sterilising treatment (reducing sugar in the food and amine substance at high temperature produce a kind of reaction of chocolate material) causes the brown stain of product easily, thereby influences the aesthetic quality of product, and consuming time longer.Another kind method is with after raw dairy sterilization, the cooling, by a certain percentage tilactase is joined in the product before the product can, and in storage process, tilactase is decomposed into glucose and semi-lactosi with the lactose in the cow's milk.This method required equipment investment is low, and the color and luster of product changes little, and when still adding enzyme, the cow's milk after the sterilization is subjected to microbiological contamination easily, and the difficult control action time of enzyme, may need extra sterilisation step, for example UHT or UV etc. after the enzyme reaction.
Thermus thermophilus HB27 is a very thermophilic widely bacterial classification of a kind of research, and genetic resources wherein is very abundant.Because its living environment temperature height, the nutrition poorness causes the character of the enzyme system in its pathways metabolism and special.So far, there have been many genes to be cloned and in different expression systems, express, comprised many glycoside hydrolases, for example amylase and glucuroide etc. from Thermus thermophilus HB27.The thermotolerance of these enzymes is all very high, and optimum temperuture is between the 60-95 degree.At present also without any the report of being cloned and expressing from the beta-galactosidase gene of Thermus thermophilus HB27, and the protein sequence of this enzyme and other species difference are bigger, even also be not more than 30% with the homology of the Thermus thermophilus A4 bacterial classification of same subspecies.Utilize the resistant to elevated temperatures character of the beta-galactosidase enzymes of Thermusthermophilus HB27, can set up and be applicable to milk-product pasteurization technology.
Summary of the invention
Technical problem to be solved by this invention provides a kind of recombinant bacterial strain of expressing beta-galactosidase enzymes, and the expressed high temperature resistant beta-galactosidase enzymes of this bacterial strain is applicable to the milk-product pasteurization.
The technical problem that the present invention also will solve provides the construction process of above-mentioned recombinant bacterial strain.
The technical problem that the present invention will solve at last provides the application of above-mentioned recombinant bacterial strain in producing high temperature resistant beta-galactosidase enzymes.
A kind of recombinant bacterial strain of expressing beta-galactosidase enzymes, this bacterial strain are the pichia spp of having integrated the beta-galactosidase gene bgal that derives from thermus thermophilus (Thermus thermophilus) HB27 on the genomic dna.
The construction process of the recombinant bacterial strain of above-mentioned expression beta-galactosidase enzymes, to be cloned among the yeast expression vector pPIC9K from the beta-galactosidase gene bgal of thermus thermophilus (Thermusthermophilus) HB27, after utilizing SacI restriction enzyme linearized vector, it is converted in the pichia spp, utilizes the G418 microbiotic to carry out the multiple copied transformant screening and obtain.
The recombinant bacterial strain of above-mentioned expression beta-galactosidase enzymes efficiently expresses the method for beta-galactosidase enzymes, it is characterized in that with methyl alcohol being that inductor inducing culture recombinant bacterial strain produces enzyme.Cultivate thalli growth 35h, OD with the 3L fermented liquid
600After reaching 450, add form with stream and add methyl alcohol, the adding total amount is 1.0～1.5L, and induction time is 40～48 hours.
The application of the recombinant bacterial strain of above-mentioned expression beta-galactosidase enzymes in the fermentative production beta-galactosidase enzymes.The condition of the beta-galactosidase enzymes hydrolyzes lactose that recombinant bacterial strain of the present invention produced is: optimal pH is 6.5, reaches half that maximum enzyme is lived at pH5.3 and this beta-galactosidase enzymes of 7.6 places, and this pH scope meets the soda acid scope of most of food; Optimum temperuture is 70 ℃, and when temperature continued to increase, the Denaturation of zymoprotein made the strong decline of enzyme living drama.No matter whether add halfcystine, the optimum temperuture of this enzyme does not all have considerable change.
The used pichia spp of the present invention is a kind of eukaryotic expression system efficiently, efficiently express tilactase with it many-sided advantage is arranged: the widespread use of (1) pichia spp Ceng Zuowei single cell protein, itself just has good security, and, do not contain Toxic matter and pyrogen in the yeast culture base.(2) pichia spp has protein excretion system efficiently.We adopt zymic a factor signal skin sequence with the tilactase direct secretion expressed in substratum, will simplify the purifying process of enzyme greatly like this, reduce the production cost of enzyme.(3) its high-cell density, low-cost fermentation process are generally adopted, and employed carbon source, nitrogenous source, salt, trace element etc. all are the general industry raw material in the fermention medium, cheaply are easy to get.Utilize pichia spp to lay a good foundation for large-scale industrialization, low-cost fermentative production tilactase as the bio-reactor of galactoside expression of enzymes.(4) foreign protein of Biao Daing content height in total secretory protein.Galactosidase gene bgal secreting, expressing in yeast among the present invention, foreign protein seldom.So just simplify the separation purifying technique of target protein, reduced cost.
Beneficial effect: the beta-galactosidase enzymes that recombinant bacterial strain produced that the present invention makes up has higher thermostability, by immobilized thermophilic beta-galactosidase enzymes, degraded lactose when can accomplish to sterilize, avoided the sterilization back to add the secondary pollution that enzyme caused, do not need extra sterilisation step, and be not easy to take place the brown stain that Maillard reaction causes product.Do like this and can improve product appearance, reduce production costs.
Description of drawings
Fig. 1 recombinant plasmid pPIC9K-bgal makes up synoptic diagram.
Thalli growth and dissolved oxygen in Fig. 2 beta-galactosidase enzymes expression process.
The mensuration of Fig. 3 beta-galactosidase enzymes optimal pH.
The mensuration of Fig. 4 beta-galactosidase enzymes optimum temperuture.
The thermostability of Fig. 5 beta-galactosidase enzymes.
Fig. 6 lactose standard substance HPLC detects collection of illustrative plates.
Lactose degradation curve in the commercially available milk of Fig. 7, the i.e. relation in lactose residual content and reaction times.
Embodiment
According to following embodiment, the present invention may be better understood.Yet, those skilled in the art will readily understand that embodiment is described only to be used to illustrate the present invention, and should also can not limit the present invention described in detail in claims.
Embodiment 1:
The Biometra PCR of company instrument is adopted in the clone of bgal gene: PCR reaction.Basi gene operative techniquies such as the DNA enzyme is cut, connected, conversion and the preparation of bacterium competence are carried out with reference to the operational manual that relevant company provides.Adopt the test kit of Shanghai China Shun biotechnology company limited, extract T.thermophilus HB27 genomic dna.With it is template, and primer is G-sense and G-anti, carries out pcr amplification.PCR carries out in 50 μ L systems, and reaction conditions is: 94 ℃ of sex change 5min, circulate 34 times by following parameter: 94 ℃ of sex change 1min, 55 ℃ of annealing 50s, 72 ℃ are extended 1.5min.Last 72 ℃ are extended 10min.The PCR reaction product is with 0.8% agarose gel electrophoresis analytical results.Behind a large amount of amplifying target genes of PCR, gel electrophoresis separation and purification PCR product behind the recovery goal gene, is connected to goal gene on the T-vector from gel.In the positive recombinant of confirming, select two and serve the order-checking of Hai Boya company.Sequencing result and the sequence of being reported are carried out the sequence alignment analysis with ClustalW software.
Bacterial classification and carrier: thermus thermophilus Thermus thermophilus HB27, available from Chinese microbiological industry DSMZ.Bgal gene clone carrier pMD18-T Vector (hereinafter to be referred as T-Vector) is available from Takara company.Yeast expression vector pPIC9K is available from Invitrogen company; Pichiapastoris expression strain GSl15 is available from Invitrogen company;
Culture medium preparation:
10x YNB (the no amino acid yeast nitrogen of 134g/L): the 134gYNB solid is dissolved in the 1L deionized water, filtration sterilization, 4 ℃ of preservations;
500x B solution (0.2g/L vitamin H): vitamin H 20mg is dissolved in the 100mL deionized water, filtration sterilization, 4 ℃ of preservations;
10x D solution (200g/L glucose): 200g D-glucose is dissolved in 1000mL water, filtration sterilization, 4 ℃ of preservations;
10x GY (glycerine of 100g/L): 100mL glycerine is dissolved in 900mL water, filtration sterilization, 4 ℃ of preservations;
100x AA (containing the every seed amino acid of 0.5g/L): take by weighing L-L-glutamic acid, L-methionine(Met), L-leucine, L-Isoleucine, each 500g of L-Methionin and be dissolved in 100mL water, filtration sterilization, 4 ℃ of preservations;
The phosphoric acid buffer seal (pH6.0) of 1mol/L: the dipotassium hydrogen phosphate of 132mL1mol/L and the potassium primary phosphate of 868ml 1mol/L are mixed, transfer pH to 6.0 with phosphoric acid and potassium hydroxide solution then, filtration sterilization, normal temperature is preserved;
The Sorbitol Solution USP of 1mol/L: the D-sorbyl alcohol of 182.1g is dissolved in the water of 1L filtration sterilization, 4 ℃ of preservations;
YPD substratum: 10g/L yeast extract, 20g/L peptone, 20g/L glucose;
MM solid medium: 13.4g/LYNB, 0.0004g/L vitamin H, 2% glucose, 1.5% agar, 0.005% L-glutamic acid, 0.005% methionine(Met), 0.005% Methionin, 0.005% leucine, 0.005% Isoleucine, 2% agar powder, all amino acid are the L type;
MD solid medium: 13.4g/L YNB, 0.0004g/L vitamin H, 2% glucose, 1.5% agar, the G418 vitriol of 0.5～4mg/L (adopting different concentration) according to screening process;
Fermention medium: 26.7mL/L 85%H
3PO
4, 0.93g/L CaSO
42H
2O, 18.2g/LK
2SO
4, 14.9g/LMgSO
47H
2O, 4.13g/L KOH, 40g/L glycerine, yeast extract paste 10g/L, peptone 20g/L, ammoniacal liquor adjust pH to 5.0 with 25%.
PTM1 nutritive salt: CuSO
45H
2O 6g/L, NaI 0.09g/L, MnCl
24H
2O 3g/L, H
3BO
30.02g/L, Na
2MoO
42H
2O 0.2g/L, CoCl
20.5g/L, ZnCl
242.2g/L, FeSO
4H
2O 65g/L, biotin 0.2g/L, H
2SO
45.0mL/L.(adding 4.35mLPTM1 nutritive salt in the 1L fermention medium)
The stream liquid feeding: 25% ammoniacal liquor: 500mL, keep fermentation pH 5.0.50% glycerine: 500mL glycerine adds deionized water to 1L, sterilization back Ensure Liquid salt 12mL.100% methyl alcohol: 1L methyl alcohol adds 12mL nutritive salt.
Primer: according to bgal gene order information, with Prime premier software design pcr amplification primer.
(9K-sense EcoRI) is: 5 '-cggaattcatgcggctggaccccaaccacc-3 ' upstream primer;
(9K-anti NotI) is: 5 '-gccaccttgcggccgcctactccgcgagaa-3 ' downstream primer.
All primers can betting office synthesize by the Shen, Shanghai.
The structure of pichia spp recombinant expression plasmid: recombinant plasmid T-bgal is carried out pcr amplification with 9K-sense and 9K-anti primer, PCR carries out in 50 μ L systems, reaction conditions is: 94 ℃ of sex change 5min, circulate 34 times by following parameter: 94 ℃ of sex change 1min, 55 ℃ of annealing 50s, 72 ℃ are extended 1.5min.Last 72 ℃ are extended 10min.Reclaim the fragment (bgal gene) of about 1.8kb, with EcoRI, NotI double digestion yeast expression vector pPIC9K and recovery.16 ℃ of connections, CaCl
2Method transformed into escherichia coli DH5 α is applied to LB (Amp
+) flat board, plasmid, double digestion evaluation and screening pichia spp recombinant expression plasmid, called after pPIC9K-bgal are cultivated and extracted to picking list bacterium colony.The building process of expression vector sees Fig. 1 for details.
The preparation of pichia spp competent cell: picking pichia spp recipient bacterium GS115 (His
-, Mut
+) single colony inoculation in the 10mLYPD liquid nutrient medium, 30 ℃ of shaking table overnight incubation are transferred in the 100mLYPD substratum with the inoculum size of 1% (v/v) again, 30 ℃ are cultured to OD600=1.3-1.5.4 ℃ of centrifugal 5min of 5000rpm, supernatant discarded, sterilized water with the precooling of 100mL ice is resuspended with thalline, 4 ℃ of centrifugal 10min of 5000m once more, supernatant discarded, with the sterilized water of 50mL ice precooling that thalline is resuspended, 4 ℃ of centrifugal 10mln of 5000rpm, with 20mL 1mol/L sorbyl alcohol washing 1 time, be dissolved in the sorbyl alcohol of 20mL 1mol/L ice precooling, again in order to transforming.
The electric shock of pichia spp transforms: with SacI restriction endonuclease single endonuclease digestion recombinant expression plasmid pPIC9K-bgal, make plasmid linearization.The unit point polygene inserts and can spontaneously form really in the cell, though ratio is low, accounts for the 1-10% of all HIS+ transformants, but can survey.What multiple copied inserted incident is because gene can insert in AOX1, aox1::AGR4 site or his4 site.The result produces the Mut+ phenotype in GS115, produce the Muts phenotype in KM71.Transfer to after getting 80 μ L competent cells and linearization plasmid (1～5 μ g) mixing in the electric shock cup of prior 0.2cm with the ice bath precooling, electric shock transformed yeast competent cell. (2.5KV, 5ms), the Sorbitol Solution USP that in the electric shock cup, adds the ice-cold 1mol/L of 1mL immediately, behind the mixing, be applied on the MM solid plate with every flat board 200 μ L bacterium liquid, 28 ℃ of cultivations are up to growing transformant.The His+ that grows on the MM flat board is transformed bacterium colony distinguish substratum MD flat board is selected in dibbling in yeast corresponding position sequentially.
Pichia spp efficiently expresses the screening and the expression of son: picking is inoculated in respectively after the well-grown transformant numbering on the MM flat board that (concentration is 0.5mg/L in the MD solid plate that contains different concns G418 vitriol, 1.0mg/L, 1.5mg/L, 2.0mg/L, 2.5mg/L, 3.0mg/L, 3.5mg/L), cultivate 24～72h (the dull and stereotyped growth time differences of different G418 concentration) in 28 ℃ of insulation cans, distinguish the single bacterium colony in the picking different concns G418 flat board, carry out next step abduction delivering.Whether effective for detecting expression condition, with the GS115 transformant that imports blank pPIC9K plasmid blank as secreting, expressing.
The picking mono-clonal is inoculated among the seed culture medium YPD, behind the shake-flask culture 24h, transfers in the fermentor tank of 5L, mixing speed 1000rpm, air flow 4VVM cultivates 23.5 hours DO% and rises to 80% in jar, begin to flow glycerol adding, when being cultured to 35h, OD600 reaches 450, begins stream and adds methyl alcohol, by improving the strategy of dissolved oxygen and interpolation organic nitrogen source, recombinant yeast pichia pastoris GS115 in the NBS of 5L fermentor tank, OD
600Reach 700, enzymic activity can reach 14000U/L in the fermented liquid.
Embodiment 2:
The preparation of crude enzyme liquid: get bacterium liquid behind the abduction delivering in 8000rpm, 4 ℃ of centrifugal 10min abandon supernatant.Precipitation phosphoric acid buffer (100mM, pH 6.0) washed twice, the precipitation after the washing is resuspended in the lysis buffer (the phosphoric acid buffer 1.0mM PMSF of 100mM), puts ultrasonication in the ice bath.With the 10mm probe, in 200w ultrasonication on ice, ultrasonic time 3s, interval 5s, ultrasonic altogether 8min.Bacterium liquid after supersound process is in 12000rpm, 4 ℃ of centrifugal 15min.Get supernatant liquor and be crude enzyme liquid.
Expression product is analyzed: with concentrated colloid amount mark is 5%, and the separation gel massfraction is that 10% sds polyacrylamide gel electrophoresis is investigated proteic expression.
Tilactase enzyme activity determination method: take by weighing 280mg ortho-nitrophenyl β-D-gala pyranoside (ONPG), be dissolved in earlier in the 1mL methyl alcohol, the phosphoric acid buffer with 100mM pH6.0 is settled to 100mL again, is made into the ONPG mother liquor of 20mM.Obtain the ONPG aqueous solution of different concns by the phosphoric acid buffer that adds different ONPG mother liquors of measuring and 100mM pH6.0 respectively.Before measuring enzyme and living, ONPG solution can be under corresponding temperature water-bath for some time, to guarantee the accuracy of temperature.Add crude enzyme liquid to be measured during measurement, making cumulative volume is 200 μ l, insulation for some time, measure its absorbance value then at 420nm, and system is by adding 1800 μ l 100mM dilute sulphuric acid stopped reactions.1 unit enzyme (U) alive is defined as per minute hydrolysis 1nmONPG.
The optimal pH of this beta-galactosidase enzymes hydrolysis ortho-nitrophenyl β-D-gala pyranoside (ONPG) is 6.5 as a result.This result and some are similar from the tilactase of other yeast and bacterium, and the optimal pH of most of beta-galactosidase from yeast and bacterium is all between 6.5 to 7.5.Reach half that maximum enzyme is lived at pH5.3 and this beta-galactosidase enzymes of 7.6 places, this pH scope meets the soda acid scope of most of food, and this illustrates that this enzyme is useful on the potentiality of lactose in hydrolysed milk or the sweetened condensed milk.Optimum temperuture from the beta-galactosidase enzymes of T.thermophilus is 70 ℃, and is very stable under its optimum temperuture.
Embodiment 3: lactose degradation experiment in the milk.
Commercially available milk detects through high performance liquid chromatography, and lactose-content is 42g/L.Adopt Ultimate 3000 chromatographic systems, differential refraction detector (RID), differential temperature 35 degree, chromatographic column is the NH of Chinese nation
2Post, moving phase are 80% acetonitrile, flow velocity 1ml/min, detection time 30min, appearance time 18min.
The lactose standard curve determination:
Commercially available lactose is made into the lactose solution of 0g/L-50g/L concentration with volumetric flask, detects the differential value with above-mentioned high performance liquid phase.The gained typical curve, y=0.609x+0.0452, R
2=0.9991.Fig. 6 is that lactose standard substance HPLC detects collection of illustrative plates.
Lactose degradation experiment in the commercially available milk
With milk heating in water bath to 60 ℃, add Sumylact L (being the crude enzyme liquid that obtains among embodiment 1 and the embodiment 2), its unit vigor reaches 30000U/L, sampling in per 5 minutes, the content of liquid chromatogram measuring lactose.After 30 minutes, lactose degradation reaches more than 85% in the milk.Fig. 7 is the lactose degradation curve, i.e. the relation in lactose residual content and reaction times.
Claims (4)
1. a recombinant bacterial strain of expressing beta-galactosidase enzymes is characterized in that this bacterial strain is a pichia spp of having integrated the beta-galactosidase gene bgal that derives from thermus thermophilus (Thermus thermophilus) HB27 on the genomic dna.
2. the construction process of the recombinant bacterial strain of the described expression beta-galactosidase enzymes of claim 1, it is characterized in that and to be cloned among the yeast expression vector pPIC9K from the beta-galactosidase gene bgal of thermus thermophilus (Thermus thermophilus) HB27, after utilizing SacI restriction enzyme linearized vector, it is converted in the pichia spp, utilizes the G418 microbiotic to carry out the multiple copied transformant screening and obtain.
3. the recombinant bacterial strain of the described expression beta-galactosidase enzymes of claim 1 efficiently expresses the method for beta-galactosidase enzymes, it is characterized in that with methyl alcohol being that inductor inducing culture recombinant bacterial strain produces enzyme, and every 3L fermented liquid is cultivated thalli growth 35h, OD
600After reaching 450, add form with stream and add methyl alcohol, adding total amount is the methyl alcohol of 1.0～1.5L, and induction time is 40～48h.
4. the recombinant bacterial strain of the described expression beta-galactosidase enzymes of claim 1, the beta-galactosidase enzymes of fermentative production is in the application of pasteurization.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105914345A CN102115718B (en) | 2010-12-16 | 2010-12-16 | Recombinant strain for expressing beta-galactosidase and construction method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105914345A CN102115718B (en) | 2010-12-16 | 2010-12-16 | Recombinant strain for expressing beta-galactosidase and construction method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102115718A true CN102115718A (en) | 2011-07-06 |
| CN102115718B CN102115718B (en) | 2012-10-31 |
Family
ID=44214644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105914345A Expired - Fee Related CN102115718B (en) | 2010-12-16 | 2010-12-16 | Recombinant strain for expressing beta-galactosidase and construction method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102115718B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102337254A (en) * | 2011-08-26 | 2012-02-01 | 江南大学 | Mutant of beta-galactosidase and preparation method and application thereof |
| CN102726522A (en) * | 2012-04-26 | 2012-10-17 | 山东东兴生物科技股份有限公司 | Preparation method of low-lactose pasteurized milk |
| CN103937767A (en) * | 2014-04-08 | 2014-07-23 | 昆明理工大学 | Galactosidase and polynucleotide encoding galactosidase |
| CN105039471A (en) * | 2014-04-18 | 2015-11-11 | 广东东阳光药业有限公司 | Method of increasing expression quantity of methylotrophic yeast expression system |
| CN110628792A (en) * | 2019-10-22 | 2019-12-31 | 怀化学院 | Cold-tolerant lactase gene and expression vector and protein thereof |
| CN111440782A (en) * | 2020-04-22 | 2020-07-24 | 青岛大学 | Novel β -galactosidase GalA and application thereof |
| CN111849941A (en) * | 2020-08-12 | 2020-10-30 | 青岛大学 | Novel beta-galactosidase and application thereof in degrading lactose in milk |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1258452A (en) * | 1998-12-25 | 2000-07-05 | 浙江医科大学 | Method of producing low-lactose milk with solid thermophilic bacteria lactase |
| CN1446909A (en) * | 2002-03-27 | 2003-10-08 | 中国农业科学院生物技术研究所 | Reformed lactase of Pichia pastoris and its application |
-
2010
- 2010-12-16 CN CN2010105914345A patent/CN102115718B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1258452A (en) * | 1998-12-25 | 2000-07-05 | 浙江医科大学 | Method of producing low-lactose milk with solid thermophilic bacteria lactase |
| CN1446909A (en) * | 2002-03-27 | 2003-10-08 | 中国农业科学院生物技术研究所 | Reformed lactase of Pichia pastoris and its application |
Non-Patent Citations (3)
| Title |
|---|
| 《Nature biotechnology》 20040531 Anke Henne et al. The genome sequence of the extreme thermophile Thermus thermophilus 547-553 第22卷, 第5期 * |
| 《Proceedings 2010 3rd international conference on biomedical engineering and informatics》 20101018 Yan Li et al Study on the characterization of a potential thermostable beta-galactosidase from thermus thermophilus HB27 2118-2121 , * |
| 《中国科技论文在线》 20091013 王霁昀等 http://www.paper.edu.cn/index.php/default/releasepaper/content/200910-147 耐热乳糖酶基因bgaB的主其在毕赤酵母中的表达 , * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102337254A (en) * | 2011-08-26 | 2012-02-01 | 江南大学 | Mutant of beta-galactosidase and preparation method and application thereof |
| CN102337254B (en) * | 2011-08-26 | 2013-04-17 | 江南大学 | Mutant of beta-galactosidase and preparation method and application thereof |
| CN102726522A (en) * | 2012-04-26 | 2012-10-17 | 山东东兴生物科技股份有限公司 | Preparation method of low-lactose pasteurized milk |
| CN103937767A (en) * | 2014-04-08 | 2014-07-23 | 昆明理工大学 | Galactosidase and polynucleotide encoding galactosidase |
| CN103937767B (en) * | 2014-04-08 | 2016-03-30 | 昆明理工大学 | The polynucleotide of a kind of tilactase and this enzyme of coding |
| CN105039471A (en) * | 2014-04-18 | 2015-11-11 | 广东东阳光药业有限公司 | Method of increasing expression quantity of methylotrophic yeast expression system |
| CN105039471B (en) * | 2014-04-18 | 2022-11-18 | 宜昌东阳光长江药业股份有限公司 | Method for improving expression quantity of methanol nutritional yeast expression system |
| CN110628792A (en) * | 2019-10-22 | 2019-12-31 | 怀化学院 | Cold-tolerant lactase gene and expression vector and protein thereof |
| CN110628792B (en) * | 2019-10-22 | 2021-04-20 | 怀化学院 | Cold-tolerant lactase gene and expression vector and protein thereof |
| CN111440782A (en) * | 2020-04-22 | 2020-07-24 | 青岛大学 | Novel β -galactosidase GalA and application thereof |
| CN111440782B (en) * | 2020-04-22 | 2021-09-17 | 青岛大学 | Beta-galactosidase GalA and application thereof |
| CN111849941A (en) * | 2020-08-12 | 2020-10-30 | 青岛大学 | Novel beta-galactosidase and application thereof in degrading lactose in milk |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102115718B (en) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102115718B (en) | Recombinant strain for expressing beta-galactosidase and construction method and application thereof | |
| KR101341730B1 (en) | Yeast extract with high glutamic acid content and producing method thereof | |
| CN109679864B (en) | Strain for producing transglycosylation active beta-galactosidase and method for producing galactooligosaccharide by using same | |
| CN103614313B (en) | A kind of bacterial strain and screening method thereof of producing high temperature resistant beta-galactosidase enzymes of fermenting | |
| CN105255745A (en) | Rhizopus for producing beta-glucosidase and method of producing enzyme through rhizopus fermentation | |
| CN109295037B (en) | Method for producing lactase by adopting aspergillus oryzae fermentation and produced lactase | |
| CN107227284A (en) | A kind of restructuring streptococcus zooepidemicus for the micromolecule hyaluronic acid that ferments | |
| CN105039189B (en) | A kind of genetic engineering bacterium for producing lysozyme of chicken and its structure and application | |
| CN105400728A (en) | Bacterial strain producing high-temperature-resistant beta-galactosidase and screening method thereof | |
| CN107151640B (en) | Lactobacillus acidophilus strain for producing lactase and method for preparing low-temperature lactase by using same | |
| CN117603889A (en) | Bacillus subtilis for producing acid protease for feed and application thereof | |
| CN104673769A (en) | Preparation method and application of novel lactase | |
| CN102268421A (en) | Cloning, expression and application of beta-glucosaccharase gene | |
| CN103031289A (en) | Lactase and recombinant expression engineering bacterium thereof | |
| CN109321469B (en) | Aspergillus oryzae capable of producing lactase with high yield and fermentation enzyme production method thereof | |
| CN103614355B (en) | Subtilis liquid fermenting is utilized to prepare the method for beta-galactosidase enzymes zymin | |
| CN105176849A (en) | Preparation method and application of Trichoderma reesei strain capable of highly yielding penicillium janczewskii Zaleski alpha-galactosidase | |
| CN105296448A (en) | Agarase and preparation method thereof | |
| CN108192848A (en) | A kind of Psychrobacter bacterial strain of galactopoiesis carbohydrase and the method that low temperature lactase is prepared using the bacterial strain | |
| CN1233826C (en) | Reformed lactase of Pichia pastoris and its application | |
| CN101948854A (en) | Lactase mutator, secretory expression method and application thereof | |
| CN105838761B (en) | A method of improving natamycin fermentation yield | |
| CN114806900A (en) | Engineering strain capable of secreting fiber swelling protein, construction method and application | |
| CN108330082A (en) | One plant of Lactobacillus paracasei and its application | |
| CN107254459A (en) | Heat-resisting beta amylase trehalose synthetase fusion enzyme, its expressing gene and engineering bacteria and the application for secreting the fusion enzyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121031 Termination date: 20131216 |